grant & contract proposals protocol review funding opportunities and technology transfer
photos of Research @ U I C
Back to Protocol Review Home PageHuman SubjectshES (ESCRO)
IRB Education & TrainingIRB Frequently Asked QuestionsIRB FormsIRB Meeting DeadlinesIRB Online Resources
IRB Policies & Guidelines
Jesse Brown VA Medical Center

RiSC WebQuality Improvement Program
IRB Contact Us

IRB suggestions

Board Composition and Expertise

Meeting Deadlines | Submission Guidelines | Board Composition & Expertise | Compliance with HHS and FDA

UIC holds a Federalwide Assurance (FWA) #00000083 from the Office for Human Research Protections (OHRP) in the Department of Health and Human Services (DHHS). This FWA is an agreement between DHHS and UIC to review and approve research involving human subjects in accordance with the ethical principles outlined in the Belmont Report and the DHHS regulations 45 CFR Part 46. UIC IRBs also meet the membership requirements of the U.S. Food and Drug Administration (FDA) regulations, 21 CFR Parts 50 and 56 and the U.S. Department of Education (ED), 34 CFR Parts 350 and 356. UIC's Assurance is in effect through January 18, 2011.

UIC's IRB membership includes members whose primary concerns are scientific, members whose primary concerns are non-scientific, and members who are not affiliated with UIC. IRB members do not participate in the discussion or vote on research protocols in which they may have conflicting interests.

The four UIC IRBs are composed of individuals, both female and male, reflecting the community's racial and ethnic diversity, with the following expertise and perspectives:

IRB 1 - Biomedical & Biological Science
IRB Registration
#00000115

IRB 2 - Behavioral & Social Science
IRB Registration
#00000116

IRB 3 - Biomedical & Behavioral Science
IRB Registration
#00000117

IRB 4 - Biomedical & Behavioral Science
IRB Registration
#00006412

Chair:
Patricia West-Thielke, Pharm.D.
Chair:
Susan Labott,
Ph.D.
Chair:
Paul Heckerling,
M.D.
Chair:
Kathryn Rugen,
Ph.D. and Jonathon Goldman, M.D.
•Dentistry
•Digestive and Liver
 Diseases
•Epidemiology
•Economically
 Disadvantaged

•Educationally  Disadvantaged

•Internal Medicine
•Nephrology
•Neurology
•Nursing
•Organ Transplant
•Pediatrics
•Pediatric  Hematology/Oncology
•Pharmacy Practice
•Pharmacy  Practice/Oncology
•Pharmacy Practice  Dietary  Supplements
•Pharmacology/Toxicology
•Psychiatry
•Public Health
•Pulmonary, Critical Care  and Sleep Medicine
•Regulatory Issues
•Surgery
•Community
 Representative
•UIC students and  Employees
•Children
•Child Welfare
•Clinical  Psychology
•Criminal Justice
•Disabilities and  Human Development
•Decisionally Impaired
•Dietetics
•Early Childhood  Education
•Education
•Epidemiology
•Health Research  Policy
•HIV
•K-12 in a Classroom  Setting
•Mentally  Disabled/Mentally Ill
•Neurology
•Nursing
•Pharmacy Practice
•Prisoners
•Psychiatry
•Psychiatric Nursing
•Psychology
•Pediatric Dentistry
•Psychology -  Children
•Regulatory issues
•Social Work
•Sociology Survey  Research
•Statistics
•UIC Psychology  Subject Pool
•Community  Representative
•UIC Students and  Employees
•Dentistry
•Digestive and Liver  Diseases
•Economically  Disadvantaged
•Educationally  Disadvantaged
•Education
•HIV
•Infectious  Diseases
•Internal Medicine
•K-12 in a  Classroom Setting
•Minors
•Pharmacy  Practice
•Pharmacology/
 Toxicology
•Neurology
•Oncology Nursing
•Obstetrics/
 Gynecology
•Psychology
•Psychiatry
•Regulatory Issues
•Surgery
•Community Representative
•UIC Students and  Employees
•Biomedical  Engineering 
•Decisionally  Impaired
•Digestive and Liver  Diseases
•Medical Surgical  Nursing
•Neurology
•Oncology
•Pain Management
•Pharmacy  Practice
•Pharmacy  Practice/Oncology
•Pulmonary,  Critical Care and  Sleep Medicine
•Psychiatry
•Regulatory Issues
•Social Work
•Veterans
•Community  Representative

UIC IRBs consider the review of other committees and involve ad hoc consultants as needed. The IRBs at UIC are in compliance with the guidelines promulgated by the International Conference on Harmonization to the degree they match the FDA regulations. IRB #1,#3 and #4 review research conducted at the Jesse Brown VAMC (JB VAMC, FWA#0000290).

It is UIC's policy to not routinely disclose the names of individual members serving on the IRBs. Rather this document is provided to investigators and sponsors as written assurance that the university is in compliance with the federal regulations governing the conduct of research involving human subjects.

Mitra Dutta, Ph.D.
Interim Vice Chancellor for Research

 

back to the UIC Homepage

Copyright © 2010 The Board of Trustees of the University of Illinois.
Have a suggestion for the site? Having problems accessing this site? Contact the webmaster.


 
back to the Research home page funding opportunities Technology Transfer